-

MedMen Opens Fenway Store Location, Officially Enters Massachusetts’ Thriving Cannabis Market

LOS ANGELES--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a leading cannabis retailer with operations across the nation, today announced the opening of its newest store location in Boston’s famed Fenway Park area. Occupying 4,725 square feet of prime retail space on 120 Brookline Avenue, MedMen Fenway marks the Company’s entry into Massachusetts’ booming adult-use market.

“As we continue to execute against our aggressive growth plans as MedMen 2.0, we are excited to announce the opening of our newest location in the very heart and soul of Boston,” said Michael Serruya, Interim CEO, MedMen. “We look forward to becoming a contributing member of the vibrant Fenway Park community and to serving the Greater Boston area with best-in-class cannabis products and exceptional customer service.”

To mark the official opening of MedMen Fenway, the Company will host a grand opening celebration for the public on Wednesday, Dec. 22, from 4 to 7 p.m. Attendees will receive introductory pricing on a wide range of premium cannabis products.

MedMen Fenway will carry a full inventory of vaporizers, concentrates, pre-rolls, topicals and flower, including an array of high cannabinoid and terpene offerings and a diverse selection of brands such as Kanha, Cresco and more. These premium products will be available in-store or through in-store pickup orders placed in advance via phone or MedMen’s proprietary online ordering service for customers.

To purchase MedMen products, please visit www.medmen.com, or find a dispensary near you at https://www.medmen.com/stores.

ABOUT MEDMEN:

MedMen is a premier American cannabis retailer with an operational footprint in California, Nevada, Illinois, Arizona, Massachusetts, and Florida. MedMen offers a robust selection of high-quality products, including MedMen-owned brands MedMen Red and LuxLyte through its premium retail stores, proprietary delivery service, as well as curbside and in-store pickup. MedMen Buds, an industry-first loyalty program, provides exclusive access to promotions, product drops and content. MedMen believes that a world where cannabis is legal and regulated is safer, healthier, and happier. Learn more about MedMen at www.medmen.com.

Contacts

MEDIA CONTACT:
Lisa Weser
Email: MedMen@Trailblaze.co

INVESTOR RELATIONS CONTACT:
Email: investors@MedMen.com

MedMen Enterprises Inc.

CNSX:MMEN

Release Summary
MedMen Opens Fenway Store Location
Release Versions

Contacts

MEDIA CONTACT:
Lisa Weser
Email: MedMen@Trailblaze.co

INVESTOR RELATIONS CONTACT:
Email: investors@MedMen.com

More News From MedMen Enterprises Inc.

MedMen Announces Management and Board Changes

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company, today announced that Ellen Deutsch Harrison has stepped down as the Chief Executive Officer and a Board member effective January 19, 2024 and the Board has appointed Richard Ormond as Chief Restructuring Officer. Furthermore, Michael Serruya, Executive Chairman of the Board, who has served on the Board since August 2021, has stepped down from the Board e...

MedMen Exits Arizona Market, Completing Sale of Local Operations to MINT Cannabis

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, today announced that the Company has completed the previously announced sale of its non-core business operations in Arizona to an affiliate of Mint Cannabis (“MINT Cannabis”). The pending sale of the Company’s assets in Nevada to MINT Cannabis awaits regulatory approval for completion. “We are pleased to announce...

MedMen Provides Annual Filing Status Report

BOCA RATON, Fla.--(BUSINESS WIRE)--MedMen Enterprises Inc. (“MedMen” or the “Company”) (CSE: MMEN) (OTCQX: MMNFF), a premier cannabis company with operations across the United States, is providing this bi-weekly default status report in accordance with National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"). On November 2, 2023, the Company announced that it had been granted a management cease trade order against the Company’s CEO and CFO (“MCTO”) by its principal regulator, the Br...
Back to Newsroom